|
|
| (6 dazwischenliegende Versionen von einem Benutzer werden nicht angezeigt) |
| Zeile 1: |
Zeile 1: |
| | {{pnc}}__NOTOC__ | | {{pnc}}__NOTOC__ |
| | | | |
| | + | {{ft|I}} |
| | *'''[[Antibody-dependent enhancement ]]''' | | *'''[[Antibody-dependent enhancement ]]''' |
| | *'''[[Herd immunity ]]''' | | *'''[[Herd immunity ]]''' |
| Zeile 10: |
Zeile 11: |
| | *'''[[T cell exhaustion ]]''' | | *'''[[T cell exhaustion ]]''' |
| | *'''[[NK cells ]]''' | | *'''[[NK cells ]]''' |
| | + | |
| | + | *'''[[MDSC myeloid-derived suppressor cells]] |
| | *'''[[Antiviral immune response ]]''' | | *'''[[Antiviral immune response ]]''' |
| | *'''[[Antiviral mediators ]]''' | | *'''[[Antiviral mediators ]]''' |
| Zeile 17: |
Zeile 20: |
| | *'''[[Eosinophils ]]''' | | *'''[[Eosinophils ]]''' |
| | *'''[[Microbiome ]]''' | | *'''[[Microbiome ]]''' |
| | + | *'''[[Pneumococcal synergism]]''' -new- |
| | *'''[[Bio-misc ]]''' ''on topic biology papers which cannot be indexed by title'' | | *'''[[Bio-misc ]]''' ''on topic biology papers which cannot be indexed by title'' |
| | *'''[[Hematology ]]''' | | *'''[[Hematology ]]''' |
| Zeile 22: |
Zeile 26: |
| | *'''[[Candidate_Compounds_Covid19 |Immunopharmacology ]]''' | | *'''[[Candidate_Compounds_Covid19 |Immunopharmacology ]]''' |
| | *'''[[Diagnosis_(Laboratory) |Clinical Laboratory Dx]]''' | | *'''[[Diagnosis_(Laboratory) |Clinical Laboratory Dx]]''' |
| − |
| |
| − | 012
| |
| − |
| |
| − |
| |
| − | {{tp|p=32614178|t=2020. Pulmonary Edema in COVID19-A Neural Hypothesis.|pdf=|usr=012}}
| |
| − | {{tp|p=32638079|t=2020. Microvascular injury and hypoxic damage: emerging neuropathological signatures in COVID-19.|pdf=|usr=012}}
| |
| − | {{tp|p=32628642|t=2020. Serum IgM against SARS-CoV-2 correlates with in-hospital mortality in severe/critical patients with COVID-19 in Wuhan, China.|pdf=|usr=012}}
| |
| − | {{tp|p=32650004|t=2020. Eicosanoids: the Overlooked Storm in COVID-19?|pdf=|usr=012}}
| |
| − | {{tp|p=32628931|t=2020. ASSOCIATION OF INITIAL VIRAL LOAD IN SARS-CoV-2 PATIENTS WITH OUTCOME AND SYMPTOMS.|pdf=|usr=012}}
| |
| − | {{tp|p=32639866|t=2020. DISEQUILIBRIUM BETWEEN THE CLASSIC RENIN-ANGIOTENSIN SYSTEM AND ITS OPPOSING ARM IN SARS-COV-2 RELATED LUNG INJURY.|pdf=|usr=012}}
| |
| − | {{tp|p=32622243|t=2020. Delving deep into the structural aspects of a furin cleavage site inserted into the spike protein of SARS-CoV-2: A structural biophysical perspective.|pdf=|usr=012}}
| |
| − | {{tp|p=32611313|t=2020. Identification of a druggable binding pocket in the spike protein reveals a key site for existing drugs potentially capable of combating Covid-19 infectivity.|pdf=|usr=012}}
| |
| − | {{tp|p=32629042|t=2020. Massive transient damage of the olfactory epithelium associated with infection of sustentacular cells by SARS-CoV-2 in golden Syrian hamsters.|pdf=|usr=012}}
| |
| − | {{tp|p=32646930|t=2020. Cytokine release syndrome and the prospects for immunotherapy with COVID-19. Part 2: The role of interleukin 1.|pdf=|usr=012}}
| |
| − | {{tp|p=32645391|t=2020. Correlation between cytokines and coagulation-related parameters in patients with coronavirus disease 2019 admitted to ICU.|pdf=|usr=012}}
| |
| − | {{tp|p=32646523|t=2020. Adrenomedullin in COVID-19 induced endotheliitis.|pdf=|usr=012}}
| |
| − | {{tp|p=32643351|t=2020. Successful sequencing of the first SARS-CoV-2 genomes from Croatian patients.|pdf=|usr=012}}
| |
| − | {{tp|p=32640417|t=2020. Neuroinvasive potential of a primary respiratory pathogen SARS- CoV2: Summarizing the evidences.|pdf=|usr=012}}
| |
| − | {{tp|p=32610564|t=2020. COVID-19 as a Vascular Disease: Lesson Learned from Imaging and Blood Biomarkers.|pdf=|usr=012}}
| |
| − | {{tp|p=32646736|t=2020. Patients with COVID-19 present with low plasma citrulline concentrations that associate with systemic inflammation and gastrointestinal symptoms.|pdf=|usr=012}}
| |
| − | {{tp|p=32650275|t=2020. Reappearance of effector T cells is associated with recovery from COVID-19.|pdf=|usr=012}}
| |
| − | {{tp|p=32629393|t=2020. Illuminating COVID-19 lung disease through autopsy studies.|pdf=|usr=012}}
| |
| − | {{tp|p=32632419|t=2020. Eosinopenia and COVID-19 patients: So specific ?|pdf=|usr=012}}
| |
| − | {{tp|p=32633718|t=2020. A mechanistic model and therapeutic interventions for COVID-19 involving a RAS-mediated bradykinin storm.|pdf=|usr=012}}
| |
| − | {{tp|p=32614767|t=2020. Main Routes of Entry and Genomic Diversity of SARS-CoV-2, Uganda.|pdf=|usr=012}}
| |
| − | {{tp|p=32618497|t=2020. High neutralizing antibody titer in intensive care unit patients with COVID-19.|pdf=|usr=012}}
| |
| − | {{tp|p=32620946|t=2020. Coronary artery dilatation in a child with hyperinflammatory syndrome with SARS-CoV-2-positive serology.|pdf=|usr=012}}
| |
| − | {{tp|p=32615182|t=2020. Melatonin is a potential adjuvant to improve clinical outcomes in individuals with obesity and diabetes with coexistence of Covid-19.|pdf=|usr=012}}
| |
| − | {{tp|p=32634438|t=2020. Update on therapeutic approaches and emerging therapies for SARS-CoV-2 virus.|pdf=|usr=012}}
| |
| − | {{tp|p=32631841|t=2020. JAK inhibitors in COVID-19: need for vigilance regarding increased inherent thrombotic risk.|pdf=|usr=012}}
| |
| − | {{tp|p=32631838|t=2020. Rapid onset honeycombing fibrosis in spontaneously breathing patient with Covid-19.|pdf=|usr=012}}
| |
| − | {{tp|p=32631836|t=2020. Similarities between COVID-19 and anti-MDA5 syndrome: what can we learn for better care?|pdf=|usr=012}}
| |
| − | {{tp|p=32646049|t=2020. Mutation Patterns of Human SARS-CoV-2 and Bat RaTG13 Coronavirus Genomes Are Strongly Biased Towards C>U Transitions, Indicating Rapid Evolution in Their Hosts.|pdf=|usr=012}}
| |
| − | {{tp|p=32646047|t=2020. Protein Coding and Long Noncoding RNA (lncRNA) Transcriptional Landscape in SARS-CoV-2 Infected Bronchial Epithelial Cells Highlight a Role for Interferon and Inflammatory Response.|pdf=|usr=012}}
| |
| − | {{tp|p=32645523|t=2020. Comparative genomic signature representations of the emerging COVID-19 coronavirus and other coronaviruses: High identity and possible recombination between Bat and Pangolin coronaviruses.|pdf=|usr=012}}
| |
| − | {{tp|p=32640274|t=2020. SARS-CoV2 envelope protein: Non-synonymous mutations and its consequences.|pdf=|usr=012}}
| |
| − | {{tp|p=32641873|t=2020. Inflammation, Immunity and Immunogenetics in COVID-19: A Narrative Review.|pdf=|usr=012}}
| |
| − | {{tp|p=32621172|t=2020. Multisystem Inflammatory Syndrome in Children in COVID-19 Pandemic.|pdf=|usr=012}}
| |
| − | {{tp|p=32615316|t=2020. Characterizations of SARS-CoV-2 mutational profile, spike protein stability and viral transmission.|pdf=|usr=012}}
| |
| − | {{tp|p=32622082|t=2020. Ancestral origin, antigenic resemblance and epidemiological insights of novel coronavirus (SARS-CoV-2): Global burden and Bangladesh perspective.|pdf=|usr=012}}
| |
| − | {{tp|p=32638151|t=2020. A viral infection explanation for Kawasaki disease in general and for COVID-19 virus-related Kawasaki disease symptoms.|pdf=|usr=012}}
| |
| − | {{tp|p=32634585|t=2020. Dynamic changes of peripheral blood lymphocytes subsets in adult patients with COVID-19.|pdf=|usr=012}}
| |
| − | {{tp|p=32613447|t=2020. SARS-CoV-2-related deaths in routine forensic autopsy practice: histopathological patterns.|pdf=|usr=012}}
| |
| − | {{tp|p=32630032|t=2020. Body Composition Findings by Computed Tomography in SARS-CoV-2 Patients: Increased Risk of Muscle Wasting in Obesity.|pdf=|usr=012}}
| |
| − | {{tp|p=32629995|t=2020. Putative Roles for Peptidylarginine Deiminases in COVID-19.|pdf=|usr=012}}
| |
| − | {{tp|p=32645951|t=2020. Implications of SARS-CoV-2 Mutations for Genomic RNA Structure and Host microRNA Targeting.|pdf=|usr=012}}
| |
| − | {{tp|p=32640747|t=2020. Immunopathology of SARS-CoV-2 Infection: Immune Cells and Mediators, Prognostic Factors, and Immune-Therapeutic Implications.|pdf=|usr=012}}
| |
| − | {{tp|p=32621017|t=2020. SARS-COV-2 and eye immunity: the lesson was learned but we are not done yet. Brainstorming on possible pathophysiology inspired by ocular models.|pdf=|usr=012}}
| |
| − | {{tp|p=32642784|t=2020. Serum antibody response in critically ill patients with COVID-19.|pdf=|usr=012}}
| |
| − | {{tp|p=32624257|t=2020. Molecular mechanisms and epidemiology of COVID-19 from an allergist's perspective.|pdf=|usr=012}}
| |
| − | {{tp|p=32615258|t=2020. Lack of complications in patients with eosinophilic gastrointestinal diseases during SARS-CoV-2 outbreak.|pdf=|usr=012}}
| |
| − | {{tp|p=32639084|t=2020. Systematic profiling of ACE2 expression in diverse physiological and pathological conditions for COVID-19/SARS-CoV-2.|pdf=|usr=012}}
| |
| − | {{tp|p=32634129|t=2020. Kinetics of viral load and antibody response in relation to COVID-19 severity.|pdf=|usr=012}}
| |
| − | {{tp|p=32610587|t=2020. Does SARS-CoV-2 Trigger Stress-InducedAutoimmunity by Molecular Mimicry? A Hypothesis.|pdf=|usr=012}}
| |
| − | {{tp|p=32635302|t=2020. Atherosclerosis as Pathogenetic Substrate for Sars-Cov2 Cytokine Storm.|pdf=|usr=012}}
| |
| − | {{tp|p=32645361|t=2020. Inflammasome Activation and Pyroptosis in Lymphopenic COVID-19 Liver Patients.|pdf=|usr=012}}
| |
| − | {{tp|p=32615199|t=2020. SARS-CoV-2 detection, viral load and infectivity over the course of an infection.|pdf=|usr=012}}
| |
| − | {{tp|p=32622905|t=2020. Longitudinal anti-SARS-CoV-2 antibody profile and neutralization activity of a COVID-19 patient.|pdf=|usr=012}}
| |
| − | {{tp|p=32614392|t=2020. Clinical characteristics and factors associated with long-term viral excretion in patients with SARS-CoV-2 infection: a single center 28-day study.|pdf=|usr=012}}
| |
| − | {{tp|p=32647285|t=2020. Detection of SARS-CoV-2 in formalin-fixed paraffin-embedded tissue sections using commercially available reagents.|pdf=|usr=012}}
| |
| − | {{tp|p=32645344|t=2020. Structural features of coronavirus SARS-CoV-2 spike protein: Targets for vaccination.|pdf=|usr=012}}
| |
| − | {{tp|p=32645661|t=2020. Is the presence of lung injury in COVID-19 an independent risk factor for secondary lung cancer?|pdf=|usr=012}}
| |
| − | {{tp|p=32645660|t=2020. Is macrophages heterogeneity important in determining COVID-19 lethality?|pdf=|usr=012}}
| |
| − | {{tp|p=32650197|t=2020. Harnessing adenosine A2A receptors as a strategy for suppressing the lung inflammation and thrombotic complications of COVID-19: Potential of pentoxifylline and dipyridamole.|pdf=|usr=012}}
| |
| − | {{tp|p=32645659|t=2020. Epithelial cilia is the first line of defence against Coronavirus; addressing the observed age-gradient in the COVID-19 infection.|pdf=|usr=012}}
| |
| − | {{tp|p=32646911|t=2020. Coding-Complete Genome Sequences of Two SARS-CoV-2 Isolates from Early Manifestations of COVID-19 in Israel.|pdf=|usr=012}}
| |
| − | {{tp|p=32646908|t=2020. Coding-Complete Genome Sequence of SARS-CoV-2 Isolate from Bangladesh by Sanger Sequencing.|pdf=|usr=012}}
| |
| − | {{tp|p=32641700|t=2020. Immunological and inflammatory profiles in mild and severe cases of COVID-19.|pdf=|usr=012}}
| |
| − | {{tp|p=32641705|t=2020. Single cell transcriptome revealed SARS-CoV-2 entry genes enriched in colon tissues and associated with coronavirus infection and cytokine production.|pdf=|usr=012}}
| |
| − | {{tp|p=32648040|t=2020. Unlocking the lockdown of science and demystifying COVID-19: how autopsies contribute to our understanding of a deadly pandemic.|pdf=|usr=012}}
| |
| − | {{tp|p=32642842|t=2020. Pulmonary pathology and COVID-19: lessons from autopsy. The experience of European Pulmonary Pathologists.|pdf=|usr=012}}
| |
| − | {{tp|p=32627524|t=2020. Considerations around the SARS-CoV-2 Spike Protein with particular attention to COVID-19 brain infection and neurological symptoms.|pdf=|usr=012}}
| |
| − | {{tp|p=32650002|t=2020. ASSOCIATION OF INITIAL VIRAL LOAD IN SARS-CoV-2 PATIENTS WITH OUTCOME AND SYMPTOMS.|pdf=|usr=012}}
| |
| − | {{tp|p=32631071|t=2020. COVID-ARDS Clarified: A Vascular Endotype?|pdf=|usr=012}}
| |
| − | {{tp|p=32649217|t=2020. RV Infections in Asthmatics Increase ACE2 Expression and Cytokine Pathways Implicated in COVID-19.|pdf=|usr=012}}
| |
| − | {{tp|p=32608999|t=2020. COVID-19 Severity Correlates with Weaker T Cell Immunity, Hypercytokinemia and Lung Epithelium Injury.|pdf=|usr=012}}
| |
| − | {{tp|p=32628534|t=2020. Clinical Validity of Serum Antibodies to SARS-CoV-2: A Case-Control Study.|pdf=|usr=012}}
| |
| − | {{tp|p=32633104|t=2020. Covid-19 related IgA vasculitis.|pdf=|usr=012}}
| |
| − | {{tp|p=32636189|t=2020. Covid-19: Herd immunity is "unethical and unachievable," say experts after report of 5% seroprevalence in Spain.|pdf=|usr=012}}
| |
| − | {{tp|p=32643798|t=2020. Tackling COVID-19 infection through complement-targeted immunotherapy.|pdf=|usr=012}}
| |
| − | {{tp|p=32640169|t=2020. Potential impact of SARS-CoV-2 infection on the thymus.|pdf=|usr=012}}
| |
| − | {{tp|p=32641195|t=2020. Reply to the letter concerning Kawasaki Disease and Covid-19.|pdf=|usr=012}}
| |
| − | {{tp|p=32638018|t=2020. Single-cell analysis of SARS-CoV-2 receptor ACE2 and spike protein priming expression of proteases in the human heart.|pdf=|usr=012}}
| |
| − | {{tp|p=32636454|t=2020. Infection with novel coronavirus (SARS-CoV-2) causes pneumonia in Rhesus macaques.|pdf=|usr=012}}
| |
| − | {{tp|p=32639942|t=2020. Response of anti-SARS-CoV-2 total antibodies to nucleocapsid antigen in COVID-19 patients: a longitudinal study.|pdf=|usr=012}}
| |
| − | {{tp|p=32639941|t=2020. The early antibody response to SARS-Cov-2 infection.|pdf=|usr=012}}
| |
| − | {{tp|p=32638022|t=2020. Direct evidence of active SARS-CoV-2 replication in the intestine.|pdf=|usr=012}}
| |
| − | {{tp|p=32645713|t=2020. Microbiota and Covid-19. Which came first, the chicken or the egg?|pdf=|usr=012}}
| |
| − | {{tp|p=32645228|t=2020. Angiotensin II Receptors - Impact for COVID-19 Severity.|pdf=|usr=012}}
| |
| − | {{tp|p=32631463|t=2020. COVID-19: Yin and Yang and Herd Immunity.|pdf=|usr=012}}
| |
| − | {{tp|p=32645207|t=2020. Basic Immunology may lead to translational therapeutic rationale:: SARS-CoV-2 and Rheumatic Diseases.|pdf=|usr=012}}
| |
| − | {{tp|p=32635753|t=2020. Pathology and pathogenicity of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2).|pdf=|usr=012}}
| |
| − | {{tp|p=32614086|t=2020. Insights into pathogenesis of fatal COVID-19 pneumonia from histopathology with immunohistochemical and viral RNA studies.|pdf=|usr=012}}
| |
| − | {{tp|p=32629518|t=2020. Inflammatory Cell Infiltration of Adrenals in COVID-19.|pdf=|usr=012}}
| |
| − | {{tp|p=32643416|t=2020. SARS-CoV-2 Receptor ACE2 is upregulated in Colonic Organoids from Hypertensive Rats.|pdf=|usr=012}}
| |
| − | {{tp|p=32615317|t=2020. Gene signatures of SARS-CoV/SARS-CoV-2-infected ferret lungs in short- and long-term models.|pdf=|usr=012}}
| |
| − | {{tp|p=32624498|t=2020. COVID 19 vaccination lessons from Japanese anti-HPV vaccination lobby.|pdf=|usr=012}}
| |
| − | {{tp|p=32643586|t=2020. On the potential role of exosomes in the COVID-19 reinfection/reactivation opportunity.|pdf=|usr=012}}
| |
| − | {{tp|p=32639183|t=2020. The Inter-alpha-Trypsin Inhibitor Family: Versatile Molecules in Biology and Pathology.|pdf=|usr=012}}
| |
| − | {{tp|p=32640487|t=2020. BTK/ITK dual inhibitors: Modulating immunopathology and lymphopenia for COVID-19 therapy.|pdf=|usr=012}}
| |
| − | {{tp|p=32644266|t=2020. Immune responses and pathogenesis in persistently PCR-positive patients with SARS-CoV-2 infection.|pdf=|usr=012}}
| |
| − | {{tp|p=32644223|t=2020. Duration of SARS-CoV-2 RNA shedding and factors associated with prolonged viral shedding in patients with COVID-19.|pdf=|usr=012}}
| |
| − | {{tp|p=32639581|t=2020. Changes in RT-PCR test results and symptoms during the menstrual cycle of female individuals infected with SARS-CoV-2: Report of two cases.|pdf=|usr=012}}
| |
| − | {{tp|p=32633840|t=2020. The variability of the serological response to SARS corona virus-2: Potential resolution of ambiguity through determination of avidity (functional affinity).|pdf=|usr=012}}
| |
| − | {{tp|p=32633815|t=2020. An update on the origin of SARS-CoV-2: Despite closest identity, bat (RaTG13) and pangolin derived coronaviruses varied in the critical binding site and O-linked glycan residues.|pdf=|usr=012}}
| |
| − | {{tp|p=32642770|t=2020. Proteome-wide Data Analysis Reveals Tissue-specific Network Associated with SARS-CoV-2 Infection.|pdf=|usr=012}}
| |
| − | {{tp|p=32640066|t=2020. Hyperinflammatory shock related to COVID-19 in a patient presenting with multisystem inflammatory syndrome in children: First case from Iran.|pdf=|usr=012}}
| |
| − | {{tp|p=32641486|t=2020. Genomic Analysis of Early SARS-CoV-2 Variants Introduced in Mexico.|pdf=|usr=012}}
| |
| − | {{tp|p=32622377|t=2020. Kawasaki disease in the COVID-19 era: a distinct clinical phenotype?|pdf=|usr=012}}
| |
| − | {{tp|p=32611256|t=2020. Continuous high-dose ivermectin appears to be safe in patients with acute myelogenous leukemia and could inform clinical repurposing for COVID-19 infection.|pdf=|usr=012}}
| |
| − | {{tp|p=32640127|t=2020. Case 23-2020: A 76-Year-Old Woman Who Died from Covid-19.|pdf=|usr=012}}
| |
| − | {{tp|p=32641847|t=2020. A COVID-19 model.|pdf=|usr=012}}
| |
| − | {{tp|p=32647358|t=2020. Revealing COVID-19 transmission in Australia by SARS-CoV-2 genome sequencing and agent-based modeling.|pdf=|usr=012}}
| |
| − | {{tp|p=32647346|t=2020. SARS-CoV-2 and bat RaTG13 spike glycoprotein structures inform on virus evolution and furin-cleavage effects.|pdf=|usr=012}}
| |
| − | {{tp|p=32616673|t=2020. Primary exposure to SARS-CoV-2 protects against reinfection in rhesus macaques.|pdf=|usr=012}}
| |
| − | {{tp|p=32638509|t=2020. The interface between coronaviruses and host cell RNA biology: Novel potential insights for future therapeutic intervention.|pdf=|usr=012}}
| |
| − |
| |
| − | {{tp|p=32611670|t=2020. Angiotensin-converting enzyme 2, a SARS-CoV-2 receptor, is upregulated by interleukin-6 via STAT3 signaling in synovial tissues.|pdf=|usr=012}}
| |
| − | {{tp|p=32627126|t=2020. COVID-19: Are we dealing with a multisystem vasculopathy in disguise of a viral infection?|pdf=|usr=012}}
| |
| − | {{tp|p=32641482|t=2020. LY6E Restricts the Entry of Human Coronaviruses, Including the Currently Pandemic SARS-CoV-2.|pdf=|usr=012}}
| |
| − | {{tp|p=32622376|t=2020. Emergence of Kawasaki disease related to SARS-CoV-2 infection in an epicentre of the French COVID-19 epidemic: a time-series analysis.|pdf=|usr=012}}
| |
| − | {{tp|p=32619412|t=2020. Endothelial cells orchestrate COVID-19 coagulopathy.|pdf=|usr=012}}
| |
| − | {{tp|p=32619411|t=2020. Endotheliopathy in COVID-19-associated coagulopathy: evidence from a single-centre, cross-sectional study.|pdf=|usr=012}}
| |
| − | {{tp|p=32616514|t=2020. Pathogenesis of COVID-19 from the Perspective of the Damage-Response Framework.|pdf=|usr=012}}
| |
| − | {{tp|p=32629204|t=2020. A hypothesis on the role of the human immune system in covid-19.|pdf=|usr=012}}
| |
| − | {{tp|p=32622045|t=2020. Integrated Approaches to Reveal Mechanisms by which RNA Viruses Reprogram the Cellular Environment.|pdf=|usr=012}}
| |
| − | {{tp|p=32616647|t=2020. Complete Genome Sequence of a 2019 Novel Coronavirus (SARS-CoV-2) Strain Causing a COVID-19 Case in Morocco.|pdf=|usr=012}}
| |
| − | {{tp|p=32616644|t=2020. Genome Sequencing of a Severe Acute Respiratory Syndrome Coronavirus 2 Isolate Obtained from a South African Patient with Coronavirus Disease 2019.|pdf=|usr=012}}
| |
| − | {{tp|p=32620916|t=2020. Histiocytic hyperplasia with hemophagocytosis and acute alveolar damage in COVID-19 infection.|pdf=|usr=012}}
| |
| − | {{tp|p=32632085|t=2020. Marked T cell activation, senescence, exhaustion and skewing towards TH17 in patients with COVID-19 pneumonia.|pdf=|usr=012}}
| |
| − | {{tp|p=32612128|t=2020. High-altitude populations need special considerations for COVID-19.|pdf=|usr=012}}
| |
| − | {{tp|p=32636479|t=2020. Pre-existing immunity to SARS-CoV-2: the knowns and unknowns.|pdf=|usr=012}}
| |
| − | {{tp|p=32636475|t=2020. SARS-CoV-2-specific T cells without antibodies.|pdf=|usr=012}}
| |
| − | {{tp|p=32629960|t=2020. Evidence for SARS-CoV-2 Infection of Animal Hosts.|pdf=|usr=012}}
| |
| − | {{tp|p=32640525|t=2020. Molecular Aspects of COVID-19 Differential Pathogenesis.|pdf=|usr=012}}
| |
| − | {{tp|p=32627515|t=2020. Dysregulation of the immune system as a driver of the critical course of the novel coronavirus disease 2019.|pdf=|usr=012}}
| |
| − | {{tp|p=32638966|t=2020. Immunological aspects of coronavirus disease during pregnancy: an integrative review.|pdf=|usr=012}}
| |
| − | {{tp|p=32621057|t=2020. The use of SARS-CoV-2-related coronaviruses from bats and pangolins to polarize mutations in SARS-Cov-2.|pdf=|usr=012}}
| |
| − | {{tp|p=32616709|t=2020. Mapping the T cell response to COVID-19.|pdf=|usr=012}}
| |
| − | {{tp|p=32619819|t=2020. S2 Subunit of SARS-nCoV-2 Interacts with Tumor Suppressor Protein p53 and BRCA: an In Silico Study.|pdf=|usr=012}}
| |
| − | {{tp|p=32615987|t=2020. Histopathological findings in a COVID-19 patient affected by ischemic gangrenous cholecystitis.|pdf=|usr=012}}
| |
